Mark Coles
Mark Coles is a prominent researcher at the Kennedy Institute of Rheumatology, specializing in immune function and human therapeutics.
His work at the Coles Laboratory involves a combination of experimental and computational approaches to delve into immune cell-stromal cell interactions and remodelling in various health conditions.
Mark's research specifically focuses on Innate Lymphoid Cells (ILCs) in epithelial tissue repair, multi-scale agent-based models for immune responses, biophysics of immune responses, and stromal cells' role in anti-tumour immune responses.
He holds a Bachelor's Degree in Microbiology from Cornell University and a Ph.D. in Molecular Cell Biology from the University of California, Berkeley.
Mark Coles has held various key positions, including Professor at Kennedy Institute of Rheumatology, Co-Founder at Mestag Therapeutics, and roles at University of Oxford, Reuben College at Parks College, University of York, and National Institute for Medical Research.
